Author contribution
All authors have made substantial contribution to the case report.SY (Consultant obstetrician) and MH (Pharmacy Executive Director) has contributed to the conceptualization of the case report and were responsible for supervision, planning and execution.SH is a senior consultant and head of obstetric emergency who was involved in the initial assessment of the case. ZM is the primary obstetrician (senior consultant) who was involved in treating the case along with TR & IB (obstetric consultant) andMJ (specialist obstetrician). AA is a senior research fellow and ECMO consultant who managed the case in intensive care unit.AM is a senior consultant at the emergency department, involved in the initial management of the case. MM is infectious disease consultant and provided valuable input to the manuscript and managing the COVID-19 and related complications. AT and FM have contributed by interpreting the laboratory and radiological findings.HS is consultant neonatologist who managed the newborn in the NICU. PR and WK are pharmacy administrative, involved in the acquisition of the financial support, scientific review and verification for the validity of content. BT is a clinical pharmacy specialist and doctoral researcher who took the lead in writing the manuscript in consultation with SY, MH, AM, PR, FM . All authors discussed, reviewed and edited the case report. All authors agreed to the final version prior to its submission.